{"altmetric_id":1071490,"counts":{"readers":{"mendeley":55,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["132138255805"],"posts_count":1},"total":{"posts_count":9},"twitter":{"unique_users_count":8,"unique_users":["TraceyBaas","caincw","JoanneKotz","ElementoLab","LifeOkklo","MOR_MBR","portefeuillefun","MOR_CGL"],"posts_count":8}},"selected_quotes":["First #SciBX Innovation Summit report on Macrocycles is now online and free to read! See also","Another good overview of the sector Lanthio Pharma is active in -","Bringing Macrocycles Full Circle, first-of-kind Roadmap to Innovation with macrocycles and constrained peptides. #SciBX","Great editorial on (cell-permable) #macrocycles. No mention of #cyclodextrins? Nice fit with #okklo strategy !"],"citation":{"altmetric_jid":"55f17ebe2a83ee43768b456f","authors":["Joanne Kotz"],"doi":"10.1038\/scibx.2012.1176","endpage":"","first_seen_on":"2012-11-15T22:45:54+00:00","issns":["false","1945-3477"],"journal":"Science-Business eXchange","last_mentioned_on":1354001586,"links":["http:\/\/www.nature.com\/scibx\/journal\/v5\/n45\/full\/scibx.2012.1176.html"],"pubdate":"2012-11-15T00:00:00+00:00","publisher":"Nature Publishing Group","startpage":"","title":"Bringing macrocycles full circle","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/bringing-macrocycles-full-circle"},"altmetric_score":{"score":6.35,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":6.35},"context_for_score":{"all":{"total_number_of_other_articles":5038248,"mean":5.9640871386398,"rank":775211,"this_scored_higher_than_pct":84,"this_scored_higher_than":4260822,"rank_type":"exact","sample_size":5038248,"percentile":84},"similar_age_3m":{"total_number_of_other_articles":82819,"mean":5.6870174116738,"rank":12760,"this_scored_higher_than_pct":84,"this_scored_higher_than":70013,"rank_type":"exact","sample_size":82819,"percentile":84},"this_journal":{"total_number_of_other_articles":277,"mean":2.1201086956522,"rank":17,"this_scored_higher_than_pct":93,"this_scored_higher_than":260,"rank_type":"exact","sample_size":277,"percentile":93},"similar_age_this_journal_3m":{"total_number_of_other_articles":7,"mean":0.76666666666667,"rank":1,"this_scored_higher_than_pct":85,"this_scored_higher_than":6,"rank_type":"exact","sample_size":7,"percentile":85}}},"demographics":{"poster_types":{"member_of_the_public":7,"science_communicator":1},"users":{"twitter":{"cohorts":{"Scientists":2,"Members of the public":5,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":3,"Researcher":18,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":17,"Student  > Postgraduate":1,"Other":7,"Student  > Master":4,"Student  > Bachelor":1,"Professor":3},"by_discipline":{"Chemistry":34,"Social Sciences":1,"Agricultural and Biological Sciences":14,"Business, Management and Accounting":1,"Biochemistry, Genetics and Molecular Biology":4,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"US":4,"NL":1,"DE":3},"mendeley":{"SE":1,"KR":1,"IE":1,"PL":1,"GB":3,"DE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/TraceyBaas\/statuses\/269447502741241858","license":"public","citation_ids":[1071490],"posted_on":"2012-11-16T14:31:05+00:00","author":{"name":"TraceyBaas","url":"http:\/\/urbest.urmc.edu","image":"https:\/\/pbs.twimg.com\/profile_images\/2701748238\/199f1ebbe068aa898886dacc1fa183d2_normal.jpeg","description":"graduate education aficionado, word nerd, new assistant professor, infectious disease maven & sweep rowing addict #scicomm #withaPhD","id_on_source":"TraceyBaas","tweeter_id":"394032029","geo":{"lt":43.15478,"ln":-77.61556,"country":"US"},"followers":766},"tweet_id":"269447502741241858"},{"url":"http:\/\/twitter.com\/caincw\/statuses\/269209608197922816","license":"public","citation_ids":[1071490],"posted_on":"2012-11-15T22:45:46+00:00","author":{"name":"Chris Cain","image":"https:\/\/pbs.twimg.com\/profile_images\/633392035655905284\/J9IjX4Su_normal.jpg","description":"Healthcare\/therapeutics VC at Apple Tree Partners. Fan of bikes, hikes, beaches, biotech and all things microbial.","id_on_source":"caincw","tweeter_id":"389686530","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":188},"tweet_id":"269209608197922816"},{"url":"http:\/\/twitter.com\/JoanneKotz\/statuses\/269213837054590980","license":"datasift","rt":["caincw"],"citation_ids":[1071490],"posted_on":"2012-11-15T23:02:35+00:00","author":{"name":"Joanne Kotz","url":"https:\/\/www.linkedin.com\/in\/joannekotz","image":"https:\/\/pbs.twimg.com\/profile_images\/695689997400281090\/ZZ1yyrEW_normal.jpg","description":"Chemical biology, drug discovery, rare diseases, chordoma, Jnana Tx, hoping to make a difference (opinions are my own)","id_on_source":"JoanneKotz","tweeter_id":"310465105","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":522},"tweet_id":"269213837054590980"},{"url":"http:\/\/twitter.com\/ElementoLab\/statuses\/269226665169797120","license":"public","rt":["caincw"],"citation_ids":[1071490],"posted_on":"2012-11-15T23:53:33+00:00","author":{"name":"Olivier Elemento","url":"http:\/\/physiology.med.cornell.edu\/faculty\/elemento\/lab\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1793980317\/OE-outside_normal.jpg","description":"Associate Professor and Associate Director, Institute for Computational Biomedicine @weillcornell.","id_on_source":"ElementoLab","tweeter_id":"464159257","geo":{"lt":40.71427,"ln":-74.00597,"country":"US"},"followers":2384},"tweet_id":"269226665169797120"},{"url":"http:\/\/twitter.com\/LifeOkklo\/statuses\/272362160875786242","license":"public","citation_ids":[1071490],"posted_on":"2012-11-24T15:32:54+00:00","author":{"name":"Okklo Life Sciences","url":"http:\/\/www.okklo.com","image":"https:\/\/pbs.twimg.com\/profile_images\/674210981640318976\/eISwNz1m_normal.jpg","description":"novel therapeutic approaches using cyclodextrin-based technology - with a focus on orphan & neglected diseases","id_on_source":"LifeOkklo","tweeter_id":"469174369","geo":{"lt":52.5,"ln":5.75,"country":"NL"},"followers":129},"tweet_id":"272362160875786242"},{"url":"http:\/\/twitter.com\/MOR_MBR\/statuses\/273326314717581312","license":"public","citation_ids":[1071490],"posted_on":"2012-11-27T07:24:06+00:00","author":{"name":"Mario Brkulj","url":"http:\/\/www.macbiocom.com\/team\/mario-brkulj.php","image":"https:\/\/pbs.twimg.com\/profile_images\/424162995518701569\/8LZ1HY9W_normal.jpeg","description":"Life science PR & IR at @macbiocom, @MorphoSys alumni; science background, former journalist, soccer fan, bringing #socialmedia to healthcare communications","id_on_source":"MOR_MBR","tweeter_id":"33931334","geo":{"lt":51.5,"ln":10.5,"country":"DE"},"followers":650},"tweet_id":"273326314717581312"},{"url":"http:\/\/twitter.com\/portefeuillefun\/statuses\/273327518780620800","license":"public","rt":["MOR_MBR"],"citation_ids":[1071490],"posted_on":"2012-11-27T07:28:53+00:00","author":{"name":"Schulz","url":"http:\/\/critiquecinematographique.com","image":"https:\/\/pbs.twimg.com\/profile_images\/701617236566523904\/FBtKMQVa_normal.jpg","description":"One day people will say, just why didn't I follow that guy and buy one of his photographs :)","id_on_source":"portefeuillefun","tweeter_id":"427877977","geo":{"lt":51.22172,"ln":6.77616,"country":"DE"},"followers":2759},"tweet_id":"273327518780620800"},{"url":"http:\/\/twitter.com\/MOR_CGL\/statuses\/273328581852147714","license":"public","rt":["MOR_MBR"],"citation_ids":[1071490],"posted_on":"2012-11-27T07:33:06+00:00","author":{"name":"ClaudiaGutjahrLoeser","url":"http:\/\/www.morphosys.com","image":"http:\/\/pbs.twimg.com\/profile_images\/1187005472\/Claudia_Gutjahr-Loeser_8182_Quadr_normal.jpg","description":"Head of Corporate Communications & Investor Relations of MorphoSys AG","id_on_source":"MOR_CGL","tweeter_id":"224940128","geo":{"lt":48.10965,"ln":11.45195,"country":"DE"},"followers":106},"tweet_id":"273328581852147714"}],"facebook":[{"title":"Challenges and innovation opportunities in macrocycle-based drug discovery : SciBX: Science-Business","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=445424875516095&id=132138255805","citation_ids":[1071490],"posted_on":"2012-11-20T19:25:01+00:00","summary":"At the recently held SciBX Innovation in Drug Discovery and Development Summit on         macrocycles and constrained peptides, participants identified four areas of science in which         work is needed to enable innovation in the field: pharmacok","author":{"name":"Molecular Creativity","url":"https:\/\/www.facebook.com\/132138255805","facebook_wall_name":"Molecular Creativity","image":"https:\/\/graph.facebook.com\/132138255805\/picture","id_on_source":"132138255805"}}]}}